C-MER Medical Holdings (03309) Announces Share Repurchase and Treasury Shares Update

Bulletin Express

Feb 24

C-MER Medical Holdings Limited (03309) reported the repurchase of 0.20 million ordinary shares on 24 February 2026 at prices ranging from HKD 1.54 to HKD 1.57, with a volume-weighted average price of approximately HKD 1.56. The total payment for this transaction was HKD 311,200.

After the repurchase, the company holds 20.62 million shares as treasury shares, increased from 20.42 million. The number of issued shares excluding treasury shares is 1.21 billion, while total issued shares remain at 1.23 billion.

According to the repurchase mandate dated 19 May 2025, C-MER Medical Holdings Limited is authorized to repurchase up to 125.56 million shares. A total of 0.20 million shares have been repurchased so far under this mandate, representing approximately 0.0159% of the total issued shares (excluding treasury shares) as of the date of the mandate.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/news/1187154513"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1187154513\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1187154513?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-02-24 18:26","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1187154513","market":"hk","top_or_hot":-1,"title":"C-MER Medical Holdings (03309) Announces Share Repurchase and Treasury Shares Update","media":"Bulletin Express","content":"<p>C-MER Medical Holdings Limited (03309) reported the repurchase of 0.20 million ordinary shares on 24 February 2026 at prices ranging from HKD 1.54 to HKD 1.57, with a volume-weighted average price of approximately HKD 1.56. The total payment for this transaction was HKD 311,200.</p>\n<p>After the repurchase, the company holds 20.62 million shares as treasury shares, increased from 20.42 million. The number of issued shares excluding treasury shares is 1.21 billion, while total issued shares remain at 1.23 billion.</p>\n<p>According to the repurchase mandate dated 19 May 2025, C-MER Medical Holdings Limited is authorized to repurchase up to 125.56 million shares. A total of 0.20 million shares have been repurchased so far under this mandate, representing approximately 0.0159% of the total issued shares (excluding treasury shares) as of the date of the mandate.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>C-MER Medical Holdings (03309) Announces Share Repurchase and Treasury Shares Update</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nC-MER Medical Holdings (03309) Announces Share Repurchase and Treasury Shares Update\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-02-24 18:26</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>C-MER Medical Holdings Limited (03309) reported the repurchase of 0.20 million ordinary shares on 24 February 2026 at prices ranging from HKD 1.54 to HKD 1.57, with a volume-weighted average price of approximately HKD 1.56. The total payment for this transaction was HKD 311,200.</p>\n<p>After the repurchase, the company holds 20.62 million shares as treasury shares, increased from 20.42 million. The number of issued shares excluding treasury shares is 1.21 billion, while total issued shares remain at 1.23 billion.</p>\n<p>According to the repurchase mandate dated 19 May 2025, C-MER Medical Holdings Limited is authorized to repurchase up to 125.56 million shares. A total of 0.20 million shares have been repurchased so far under this mandate, representing approximately 0.0159% of the total issued shares (excluding treasury shares) as of the date of the mandate.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"03309","symbol_name":"希玛医疗","start_time":0,"source_url":"","article_id":"1187154513","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1187154513","pubTimestamp":1771928788,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"C-MER Medical Holdings Limited (03309) reported the repurchase of 0.20 million ordinary shares on 24 February 2026 at prices ranging from HKD 1.54 to HKD 1.57, with a volume-weighted average price of...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"03309":"希玛医疗"},"translate_title":"C-MER医疗控股(03309)公布股份购回及库存股更新","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"03309":1},"content_text":"C-MER Medical Holdings Limited (03309) reported the repurchase of 0.20 million ordinary shares on 24 February 2026 at prices ranging from HKD 1.54 to HKD 1.57, with a volume-weighted average price of approximately HKD 1.56. The total payment for this transaction was HKD 311,200.\nAfter the repurchase, the company holds 20.62 million shares as treasury shares, increased from 20.42 million. The number of issued shares excluding treasury shares is 1.21 billion, while total issued shares remain at 1.23 billion.\nAccording to the repurchase mandate dated 19 May 2025, C-MER Medical Holdings Limited is authorized to repurchase up to 125.56 million shares. A total of 0.20 million shares have been repurchased so far under this mandate, representing approximately 0.0159% of the total issued shares (excluding treasury shares) as of the date of the mandate.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding,SGX","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}